Article Text

other Versions

PDF
Clinical and Molecular Characterization of Bardet–Biedl Syndrome in Consanguineous Populations: The Power of Homozygosity Mapping
  1. Leen Abu Safieh1,
  2. Mohammed Aldahmesh1,
  3. Hanan Shamseldin1,
  4. Mais Hashem1,
  5. Ranad Shaheen1,
  6. Hisham Alkuraya2,
  7. Salwa Hazzaa1,
  8. Ali Al-Rajhi2,
  9. Fowzan Alkuraya1,*
  1. 1 KFSHRC, Saudi Arabia;
  2. 2 KKESH, Saudi Arabia
  1. Correspondence to: , ; alkuraya{at}mobilyconnect.com.sa

Abstract

Bardet–Biedl syndrome (BBS) is a ciliopathy with pleiotropic effect that manifests primarily as renal insufficiency, polydactyly, retinal dystrophy, and obesity. Current phenotype/genotype correlation is insufficient to predict the likely causative mutation which makes sequencing of all 14 BBS genes often necessary but highly complicated way to identify the underlying genetic defect in affected patients. In this study we show that homozygosity mapping is a robust approach that is highly suited for genetically heterogeneous autosomal recessive disorders in populations where consanguinity is prevalent. This approach allowed us to quickly identify seven novel mutations in seven families with BBS. Some of these mutations would have been missed by unguided routine sequencing which suggests that missed mutations in known BBS genes could be more common than previously thought. This study, the largest to date on Saudi BBS families, also revealed interesting phenotypic aspects of BBS including the first report of nonsyndromic retinitis pigmentosa as a novel BBS phenotype.

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.